This:
”ResApp has received a significant amount of interest in the use of its smartphone-based diagnostic technology for the triage of COVID-19 patients and is in detailed discussions with a number of healthcare systems, including in the UK, regarding specific COVID-19 implementations and studies using ResAppDx-EU to triage patients with respiratory symptoms and prioritise patient access to over-burdened clinics.”
Ann: ResApp Builds European Market Presence, page-16
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)